Cargando...
Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials
BACKGROUND: Cough and sputum are troublesome symptoms in chronic obstructive pulmonary disease (COPD) and are associated with adverse outcomes. The efficacy of aclidinium bromide 400 µg twice daily in patients with stable COPD has been established in two phase III studies (ACCORD COPD I and ATTAIN)...
Gardado en:
| Publicado en: | BMJ Open Respir Res |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMJ Publishing Group
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5174811/ https://ncbi.nlm.nih.gov/pubmed/28074135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjresp-2016-000148 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|